Correction: Immune-related adverse events associated with nab-paclitaxel/paclitaxel combined with immune checkpoint inhibitors: a systematic review and network meta-analysis

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-03-05
DOI
https://doi.org/10.3389/fimmu.2026.1812769
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Correction: Immune-related adverse events associated with nab-paclitaxel/paclitaxel combined with immune checkpoint inhibitors: a systematic review and network meta-analysis

Boyu Fang, Shasha Jin, Weimin Cai, Wenjing Hao et al.
Frontiers in Immunology
Cancer Immunotherapy and Biomarkers
article

Correction: Immune-related adverse events associated with nab-paclitaxel/paclitaxel combined with immune checkpoint inhibitors: a systematic review and network meta-analysis

Boyu Fang, Shasha Jin, Weimin Cai, Wenjing Hao, Jing Yuan, Jun Zhang
article en

Abstract

No abstract available for this paper.
Frontiers in ImmunologyVol. 17
Fudan University (CN), Obstetrics and Gynecology Hospital of Fudan University (CN)
National Natural Science Foundation of China
Openalex Percentile: Top 32%
Cancer Immunotherapy and Biomarkers
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.